Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Adenocarcinoma, Follicular × Vemurafenib × Clear all

Sponsor

Conditions

Melanoma 29 Neoplasms 7 Neoplasm Metastasis 3 Skin Neoplasms 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Lymphoma, Non-Hodgkin 1 Leukemia, Hairy Cell 1 Histiocytosis, Langerhans-Cell 1 Hereditary Sensory and Autonomic Neuropathies 1 Hepatoblastoma 1 Glioma 1 Ependymoma 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Biliary Tract Neoplasms 1

Interventions

lenvatinib 3 Sunitinib 3 cabozantinib 2 vandetanib 1 tremelimumab 1 tanespimycin 1 pembrolizumab 1 durvalumab 1 cediranib 1 Vorinostat 1 Sorafenib 1 Pharmacogenomic Testing 1 Lenalidomide 1 Iodine-131 1 Gefitinib 1 Bortezomib 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡